| Rank | Title | Journal | Year | PubWeight™‹?› |
|---|---|---|---|---|
| 1 | Infliximab in the treatment of Crohn's disease: predictors of response in an Italian multicentric open study. | Dig Liver Dis | 2005 | 1.61 |
| 2 | Infliximab and newly diagnosed neoplasia in Crohn's disease: a multicentre matched pair study. | Gut | 2005 | 1.25 |
| 3 | Review article: monitoring the activity of Crohn's disease. | Aliment Pharmacol Ther | 2002 | 0.94 |
| 4 | The genetics of NOD-like receptors in Crohn's disease. | Tissue Antigens | 2010 | 0.89 |
| 5 | Review article: maintenance treatment of Crohn's disease. | Aliment Pharmacol Ther | 2003 | 0.87 |
| 6 | Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration. | Am J Gastroenterol | 2005 | 0.86 |
| 7 | Rofecoxib and early relapse of inflammatory bowel disease: an open-label trial. | Aliment Pharmacol Ther | 2004 | 0.84 |
| 8 | Association of caspase-9 and RUNX3 with inflammatory bowel disease. | Tissue Antigens | 2010 | 0.76 |